Access. Intelligence. Excellence
Business Operations > Benchmarking and Quality|
|Benchmarking and Quality Best Practices
Best Practices, LLC has conducted extensive research in the field of Benchmarking and Quality. Browse through and sample our published Benchmarking and Quality research in the topics below:
| || |
|Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment|
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment"
Medical Science Liaison (MSL) teams face a rapidly changing healthcare environment that requires organizations to have their MSL teams appropriately sized and deployed. Best Practices, LLC conducted this research to identify the drivers of MSL team size and explore factors affecting deployment. Insights and metrics in the study will help companies field a more efficient and effective medical field team.
Medical Liaisons: Size Of Medical Science Liaison Teams
Medical Liaisons: Effective Operations Of Medical Science Liaison Teams
SAMPLE KEY METRICS
Regional demographics of participants
Title of respondents
Geographic span of responsibility of medical affairs at participating companies
Product scope of MSLs
Factors to determine team size
Internal stakeholder needs
Deployment of medical liaisons into the field in mature and emerging markets
Factors causing increase in the number of medical science liaisons
Factors causing decrease in the number of medical science liaisons
SAMPLE KEY FINDING
Determining Medical Science Liaison Teams’ Size: Mature Markets and Emerging Markets companies employ different strategies when determining the size of Medical Science Liaisons. Mature markets companies use company or product related factors such as “Corporate Commitment to a Franchise” or “Product Life Cycle” more often than Emerging Markets companies. Emerging Markets companies typically use an external factor, “Number of Thought Leaders,” to determine Medical Science Liaison teams’ size.
This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.
Effective Thought Leader Management: Leadership, Relationships and Technology
Non-members: Click here to review a complimentary excerpt from "Effective Thought Leader Management: Leadership, Relationships and Technology"
With so many of its activities affecting new product development and performance, medical affairs is recognized as one of the most important functions within pharma organizations. Thought leader management is one of the critical responsibilities of medical affairs groups because companies look to thought leaders to inform and guide clinical programs.
Some of the key components of an effective thought leader management program include its leadership structure and approach to relationship development. Best Practices LLC performed this research study to identify how leading pharma companies structure and organize their thought leader management organizations, to examine the drivers of thought leader management relationships and to highlight new technologies used to maintain relationships.
The benchmark data in this study will help companies find better ways to create effective thought leader management strategies that will enhance and inform a critical aspect of an organization’s operations. This document includes mature and emerging markets segment analysis.
Benchmark Participant Demographics
Scope, Structure and Leadership
SAMPLE KEY METRICS
Number of products involving thought leaders
Title of person with oversight responsibility for thought leader management
Group with primary oversight for thought leader management
Drivers of thought leader management program
Importance rating of activities tied to developing thought leader relationships
Importance rating of activities tied to maintaining thought leader relationships
Value rating of various new technologies used for thought leader interactions in mature markets
Value rating of various new technologies used for thought leader interactions in emerging markets
SAMPLE KEY FINDING
Number of and Interaction Frequency with thought leader s are the Most Important Management Criteria: Within 86% of the mature market companies and all of the emerging market companies number of thought leaders and frequency of interaction with thought leaders drive thought leader management initiatives.
MSL Interactions and Clinical Trials Drive TL Relationship Development: In 70% of the mature market segment and 57% of the emerging market segment, MSL interactions is key to thought leader relationship development. In addition, 68% of the mature market and 86% of the emerging market segment reported that Funding Clinical Research is vital for building thought leader relationships.
Forty survey responses from Medical Affairs leaders at 32 pharmaceutical and medical device companies in the mature market and Emerging Markets. This report captures insights on both Mature and emerging market segments.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE